OutSee is a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery.
OutSee has raised €5.0M across 2 funding rounds from 6 investors, most recently a Seed round in Jan 2026. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-13 | Seed | €2.9M | Ahren Innovation Capital,Angel Investors,Empirical Ventures,Kadmos Capital,Panacea Venture | View deal → |
| 2025-06-24 | Seed | €2.1M | Ahren Innovation Capital,Empirical Ventures,Kadmos Capital,Panacea Ventures | View deal → |
